Evidence map›Paper›PMID 40677562›Full record

ArticleWorld journal of gastrointestinal endoscopy2025

Is endoscopic treatment a useful therapeutic option for esophageal gastrointestinal stromal tumors?

Beata Jabłońska

Abstract readLetter
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Beata JabłońskaDepartment of Digestive Tract Surgery, Medical University of Silesia, Katowice 40-752, Poland. bjablonska@poczta.onet.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Decisions regarding the management of patients with esophageal gastrointestinal tumors (EGISTs) are very challenging, as there are still no clear guidelines on the treatment of these tumors due to their rarity. Surgery remains the standard treatment, but it is known that surgical procedures performed on the esophagus are related to a high risk of serious postoperative complications and impaired quality of life. Endoscopic resection is both safe and effective for patients with low-risk EGISTs. This article presents the current therapeutic options in patients with EGISTs, including both the endoscopic and surgical approach, and discusses the results, strengths and limitations of the recent article by Xu

Indexed as

Endoscopic resectionEsophagealEsophagectomyGastrointestinal stromal tumorsSurgical enucleation

Identifiers

PMID40677562
PMCPMC12264749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.